Delivery Order SPE2DB22D1106-SPE2DB25FEUF9
Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 2, 2025, for the supply of Dalvance 500 mg vials with a contract ceiling value of $3,647.09. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. The award was made through competitive procurement with no set-aside designation....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,760.90 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child delivery order, this award falls under the company's larger...
- The Defense Logistics Agency awarded a $5,961.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dalvance 500 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $16,882.84 delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of the agency's pharmaceutical procurement operations. The award leverages AmerisourceBergen's established position as a critical federal medical vendor, particularly within the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $2,242.43 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the company's broader indefinite delivery contract vehicle with DLA. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $13,106.60 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication, with an ultimate completion date of September 8, 2025. This firm fixed price contract, awarded on September 5, 2025, utilizes no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order, this award leverages AmerisourceBergen's substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,688.81 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a specialty antibiotic used to treat bacterial skin infections. This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,377.68 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive, non-set-aside purchase. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,284.07 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 15, 2025. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with a ceiling value of $2,743.74. The award, issued on September 4, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...